A Phase II Study of SSGJ-612 Plus a HER2-Targeted ADC in HR-Positive, HER2-Low or HER2-Ultralow Expression Metastatic Breast Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Metastatic Breast Cancer
Related studies linked through entity extraction aliases.
SMP-656 for HER2-Positive Advanced Breast Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Entinostat Plus Pyrotinib and Endocrine Therapy in Advanced Triple-Positive Breast Cancer After Trastuzumab Failure
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Targeting Aurora A Kinase to Overcome Treatment Resistance in Advanced HR+/HER2+ Breast Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
CDK4/6 Inhibitors in Metastatic HR-Positive Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Multimodal Exercise and Education Program in Metastatic Breast CancerMostrar más líneas
- Status
- COMPLETED
- Phase
- NA
T-DXd Based Therapy Followed by Endocrine Therapy Plus Dual HER2 Blockade in First-line HER2+/ HR+ Metastatic Breast Cancer and Retreatment With T-DXd
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
CRYO-TOUCH: Cryoablation of the Primary Breast Tumor in Metastatic Breast Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Bioequivalence Study of Liposomal Doxorubicin 20 mg/10 mL (Doxopeg® vs Caelyx®) in Advanced Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE1
Fast-Her: Fasting Effects on Breast Cancer Treatment
- Status
- RECRUITING
- Phase
- NA
Trastuzumab Deruxtecan and Lovastatin in HER2-low and Ultralow Advanced or Metastatic Breast Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
First-in-human Diagnostic Imaging Profile of the Theranostic Pair [68Ga]Ga-DOTA-STR-17126 and Low Dose [177Lu] Lu-DOTA-STR-17126 in Patients With Advanced or Metastatic Cancer
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
Evaluation of a Patient-Centered Decision-Making Support Tool for Older Adults With Advanced Breast Cancer and Their Care Partners
- Status
- NOT_YET_RECRUITING
- Phase
- NA
A Phase I Interventional Open-label, Non-randomized Dose-escalation Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Immunogenicity, and Preliminary Anti-tumor Activity of Autologous p95HER2.CAR-TECH2Me T Cells in Patients With Selected Advanced Cancers.
- Status
- RECRUITING
- Phase
- PHASE1
HER2-positive Metastatic Breast Cancer in Kazakhstan
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Impact of Genetic Variants on the Toxicity of Antibody-Drug Conjugates in Locally Advanced or Metastatic Breast Cancer: The Role of the UGT1A1 Gene as a Predictive Biomarker of Therapeutic Response
- Status
- RECRUITING
- Phase
- N/A
A Study to Investigate the Effect of Food on the Bioavailability of Oral Paclitaxel Administered With Encequidar in Participants With Advanced Solid Tumors
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Shared Decision Making for Patients With HER2-negative Metastatic Breast Cancer (SDM-01)
- Status
- NOT_YET_RECRUITING
- Phase
- NA
A Study of HLD-0117 in Patients With Metastatic Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Sexual Health and Rehabilitation for Women With Metastatic Breast Cancer (SHARE-MC): An Educational Intervention
- Status
- NOT_YET_RECRUITING
- Phase
- NA